Clinical Development of Radiopharmaceuticals a Theranostic Pairs and Dosimetry Considerations

Anthony Fotinos discusses the clinical development and regulation of radiopharmaceuticals, emphasizing FDA guidelines for therapeutic and diagnostic applications. He highlights dosimetry considerations, the importance of effective half-lives, and the regulatory pathways for both types of radiopharmaceuticals. The presentation concludes with insights into theranostic pairs and their potential in oncology.